Meditera Tibbi Malzeme Sanayi ve Ticaret AS
Meditera Tibbi Malzeme Sanayi ve Ticaret Anonim Sirketi manufactures and sells medical devices in Turkey. The company offers breathing sytems products, including breathing circuits, breathing filters, catheter mounts, gas sampling lines, accessories, masks, and connectors. It also provides hospital products, such as barrier cream, surgical hand brushes for skin disinfection, hand and skin antisep… Read more
Meditera Tibbi Malzeme Sanayi ve Ticaret AS (MEDTR) - Total Assets
Latest total assets as of September 2025: TL3.52 Billion TRY
Based on the latest financial reports, Meditera Tibbi Malzeme Sanayi ve Ticaret AS (MEDTR) holds total assets worth TL3.52 Billion TRY as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Meditera Tibbi Malzeme Sanayi ve Ticaret AS - Total Assets Trend (2018–2024)
This chart illustrates how Meditera Tibbi Malzeme Sanayi ve Ticaret AS’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Meditera Tibbi Malzeme Sanayi ve Ticaret AS - Asset Composition Analysis
Current Asset Composition (December 2024)
Meditera Tibbi Malzeme Sanayi ve Ticaret AS's total assets of TL3.52 Billion consist of 55.3% current assets and 44.7% non-current assets.
| Asset Category | Amount (TRY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | TL0.00 | 10.8% |
| Accounts Receivable | TL426.48 Million | 15.2% |
| Inventory | TL530.46 Million | 18.9% |
| Property, Plant & Equipment | TL0.00 | 0.0% |
| Intangible Assets | TL9.80 Million | 0.4% |
| Goodwill | TL0.00 | 0.0% |
Asset Composition Trend (2018–2024)
This chart illustrates how Meditera Tibbi Malzeme Sanayi ve Ticaret AS's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Meditera Tibbi Malzeme Sanayi ve Ticaret AS's current assets represent 55.3% of total assets in 2024, a decrease from 75.3% in 2018.
- Cash Position: Cash and equivalents constituted 10.8% of total assets in 2024, up from 6.9% in 2018.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2018.
- Asset Diversification: The largest asset category is inventory at 18.9% of total assets.
Meditera Tibbi Malzeme Sanayi ve Ticaret AS Competitors by Total Assets
Key competitors of Meditera Tibbi Malzeme Sanayi ve Ticaret AS based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Meditera Tibbi Malzeme Sanayi ve Ticaret AS - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Meditera Tibbi Malzeme Sanayi ve Ticaret AS generates 0.75x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Meditera Tibbi Malzeme Sanayi ve Ticaret AS generates $ 2.61 in net profit.
Meditera Tibbi Malzeme Sanayi ve Ticaret AS - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.43 | 3.60 | 5.31 |
| Quick Ratio | 2.17 | 2.43 | 4.48 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | TL1.36 Billion | TL 1.05 Billion | TL 370.69 Million |
Meditera Tibbi Malzeme Sanayi ve Ticaret AS - Advanced Valuation Insights
This section examines the relationship between Meditera Tibbi Malzeme Sanayi ve Ticaret AS's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.23 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | 2.8% |
| Total Assets | TL2.81 Billion |
| Market Capitalization | $19.51 Million USD |
Valuation Analysis
Below Book Valuation: The market values Meditera Tibbi Malzeme Sanayi ve Ticaret AS's assets below their book value (0.01 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Meditera Tibbi Malzeme Sanayi ve Ticaret AS's assets grew by 2.8% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Meditera Tibbi Malzeme Sanayi ve Ticaret AS (2018–2024)
The table below shows the annual total assets of Meditera Tibbi Malzeme Sanayi ve Ticaret AS from 2018 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | TL2.81 Billion | +2.82% |
| 2023-12-31 | TL2.73 Billion | +148.57% |
| 2022-12-31 | TL1.10 Billion | +52.87% |
| 2021-12-31 | TL719.21 Million | +110.49% |
| 2020-12-31 | TL341.69 Million | +55.16% |
| 2019-12-31 | TL220.21 Million | +8.23% |
| 2018-12-31 | TL203.47 Million | -- |